• Observed COVID-19 variability may have u

    From ScienceDaily@1337:3/111 to All on Wed Oct 21 21:30:32 2020
    Observed COVID-19 variability may have underlying molecular sources
    Study shows how variations in SARS-CoV-2 host gene expression can be
    linked to variations in COVID-19 susceptibility and symptom severity

    Date:
    October 21, 2020
    Source:
    University of California - Riverside
    Summary:
    People have different susceptibilities to SARS-CoV-2, the virus
    behind the COVID-19 pandemic, and develop varying degrees of
    fever, fatigue, and breathing problems -- common symptoms of the
    illness. What might explain this variation? Scientists may have
    an answer to this mystery.



    FULL STORY ========================================================================== People have different susceptibilities to SARS-CoV-2, the virus behind
    the COVID-19 pandemic, and develop varying degrees of fever, fatigue,
    and breathing problems -- common symptoms of the illness. What might
    explain this variation?

    ========================================================================== Scientists at the University of California, Riverside, and University
    of Southern California may have an answer to this mystery.

    In a paper published in Informatics in Medicine Unlocked, the researchers
    show for the first time that the observed COVID-19 variability may have underlying molecular sources. The finding could help in the development
    of effective prophylactic and therapeutic strategies against the disease.

    "Based on biomarkers and molecular profiles of individuals, one would
    hope to develop better medical tests to accommodate these variations
    in monitoring virus transmission and disease pathology, which helps
    guide mitigation and treatment options," said Sika Zheng, an associate professor of biomedical sciences at the UC Riverside School of Medicine,
    who led the study.

    The SARS-CoV-2 virus hijacks human host molecules for fusion and
    virus replication, attacking human cellular functions. These human host molecules are collectively called SARS-CoV-2 host genes. The researchers systematically analyzed SARS-CoV-2 host gene expression, their variations,
    and age- and sex- dependency in the human population using large-scale genomics, transcriptomics, and proteomics.

    They first found similarity of host gene expression is generally
    correlated with tissue vulnerability to SARS-CoV-2 infection. Among the
    six most variably expressed genes in the population they identified ACE2, CLEC4G, and CLEC4M, which are known to interact with the spike protein
    of SARS-CoV-2. Higher expression of these genes likely increases the possibility of being infected and of developing severe symptoms. Other
    variable genes include SLC27A2 and PKP2, both known to inhibit virus replication; and PTGS2, which mediates fever response. The authors also identified genetic variants linked to variable expression of these genes.

    According to the Zheng, the expression profiles of these marker genes
    may help better categorize risk groups.

    "More comprehensive risk assessment can better guide the early stage of
    vaccine distribution," he said. "Tests can also be developed to include
    these molecular markers to better monitor disease progression. They
    can also be used to stratify patients to assess and ultimately enhance treatment effectiveness." In addition to identifying the most variable SARS-CoV-2 host genes, results from the study suggest genetic and
    multiple biological factors underlie the population variation in
    SARS-CoV-2 infection and symptom severity.

    "Of course, these will need confirmation with more data. But the results indicate a potential value of a large scale eQTL project to profile
    genotypes and transcriptome of COVID-19 patients," Zheng said.

    Next, the researchers plan to further analyze large scale genotypes and transcriptome data of COVID-19 patients when made available and to refine
    the results for higher association and accuracy.

    Zheng was joined in the research by Liang Chen of USC. Grants from the
    National Institutes of Health supported the study.


    ========================================================================== Story Source: Materials provided by
    University_of_California_-_Riverside. Original written by Iqbal
    Pittalwala. Note: Content may be edited for style and length.


    ========================================================================== Journal Reference:
    1. Liang Chen, Sika Zheng. Understand variability of COVID-19 through
    population and tissue variations in expression of SARS-CoV-2
    host genes.

    Informatics in Medicine Unlocked, Oct. 12, 2020; DOI: 10.1016/
    j.imu.2020.100443 ==========================================================================

    Link to news story: https://www.sciencedaily.com/releases/2020/10/201021140915.htm

    --- up 8 weeks, 2 days, 6 hours, 50 minutes
    * Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1337:3/111)